New treatment monitored for safety in kids with rare bleeding disorder
NCT ID NCT07404644
Summary
This study is monitoring how safe and effective a treatment called vonicog alfa is for children under 18 with Von Willebrand Disease, a rare bleeding disorder. Doctors in Japan will observe about 13 children receiving this treatment during normal medical care for bleeding episodes or surgeries. The main goal is to track any side effects and see how well the treatment controls bleeding over one year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VON WILLEBRAND DISEASE (VWD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Takeda selected site
RECRUITINGTokyo, Tokyo, Japan
Conditions
Explore the condition pages connected to this study.